Stock·NASDAQ·Financial Services
Nasdaq Inc (NDAQ)
- Market cap
- $58.54B
- P/E
- 28.61
- Dividend yield
- 1.15%
- Street target
- $115.50median of 18 analysts
- 52-week range
- $76.55 $104.94
NDAQ stock forecast today
Where NDAQ stands today, and what CleaRank Financial AI makes of it.
NDAQ at a glance
Nasdaq Inc (NDAQ): Buy, 72/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($95.02 and $90.48).
- Earnings NDAQ beat estimates in 7 of the 7 reports in our data, yet fell the next day after 3 of those beats.
- Insiders Insiders sold $91.2M and bought $16.8M over the last 18 months.
- Valuation P/E of 28.6 against 16.5 for the Financial Services sector: a premium to peers (+73%).
Figures as of October 26, 2026.
CleaRank Financial AI
NDAQ, or Nasdaq Inc, is rated Buy by CleaRank with a model score of 72/100.
The trend is the strongest support: the price is 15.74% above its 200-day average and 10.21% above its 50-day average, and the 50-day average is 5.02% above the 200-day. The 50-day average is $95.02 and the 200-day is $90.48. Across the past year, the price rose 18.41%.
Only on CleaRank
Figures we compute ourselves from NDAQ's own price, earnings and insider-filing history. Tap one to see it in context.
NDAQ stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $104.72 is 10.2% above the 50-day simple moving average of $95.02.Price above its 200-day average ›
The price is 15.7% above the 200-day simple moving average of $90.48.50-day average above the 200-day ›
The 50-day average ($95.02) is 5.0% above the 200-day average ($90.48), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 99% of its 52-week range, between $76.55 and $104.94.
NDAQ share price
Pick a period: each tab shows how far NDAQ has moved over it, to the last close.
Today's trading
Where NDAQ sits inside today's range and its 52-week range.
NDAQ fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/5P/E below the sector median ›
The trailing P/E of 28.61 is 73.4% above the Financial Services median of 16.5.P/S below the sector median ›
The price-to-sales ratio of 6.69 is 76.0% above the sector median of 3.8.Profitable over the last 12 months ›
Net income over the last 12 months was $2.0B on revenue of $8.8B, a net margin of 22.5%.Beat estimates in most recent reports ›
NDAQ beat the EPS estimate in 7 of the 7 reports in our data.Pays a dividend ›
The trailing dividend yield is 1.15%, or $1.20 a share a year.
Key statistics
The headline figures for NDAQ.
As of October 26, 2026, NDAQ trades at $104.72, with a market value of $58.54B, a P/E ratio of 28.61 and a dividend yield of 1.15%.
What the numbers say
CleaRank Financial AI's reading of NDAQ's valuation, growth and risks.
NDAQ's trailing P/E stands at 28.61, which is 69.8% above the Financial Services median of 16.5. The peer comparison on this page gives the P/E verdict as a premium to peers. Over the last twelve months the company earned $3.66 per share.
NDAQ is growing faster than its sector. The company keeps a net margin of 22.5% and an operating margin of 50.57%. Return on equity stands at 17.33%, above the sector median of 13.8%. On the balance sheet, debt-to-equity is 0.77, and the trailing dividend yield is 1.15%, equal to $1.20 a share a year.
Nasdaq Inc (NDAQ) beat the estimate by 1.96% in its latest quarterly report on October 22, 2026, posting EPS of $1.04 against the $1.02 analysts had expected. Despite the beat, the share price slipped 0.72% in the first session after the release.
Analysts' average EPS estimate for this fiscal year is $4.14, which would be growth of 18.9%, and $4.74 for next year (growth of 14.6%).
The P/E of 28.61, 73.4% above the sector median, puts NDAQ at a premium to peers, so weaker results would meet a higher bar. On a typical day the price of NDAQ shifts by 1.79%, the 30-day standard deviation of its daily returns, and its beta against the S&P 500 is 1.00. Insiders sold $91.2M over the last 18 months and bought $16.8M, though sales of this kind are often planned in advance and say less than purchases would.
NDAQ against the Financial Services sector
How NDAQ compares with the median Financial Services stock CleaRank tracks.
Price to earnings vs sector: NDAQ trades at a significant premium to sector peers (+73%), suggesting market expectations for superior growth or market position.
Return vs XLF: Since May 14, 2025, NDAQ has gained 29.2% against a gain of 10.0% for XLF.
Performance against XLF
NDAQ and the Financial Services sector fund over the same days.
Revenue and earnings
How much NDAQ sells, and how much of it becomes profit.
The quarterly bars end with Q2 '26 (the quarter to June 30, 2026); NDAQ reported again on October 22, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue grew 11.6% in FY2025 to $8.3B, from $7.4B a year earlier.
Profit margin: The net margin was 21.6% in FY2025, up from 15.1% the year before.
Profitable: NDAQ earned $1.8B in FY2025.
Earnings reality check
Did NDAQ beat what analysts expected, and how did the stock react?
Earnings record: NDAQ beat the analyst estimate in 7 of the 7 reports in our data.
Market reaction: The stock fell in the first session after 3 of those 7 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Oct 22, 2026after close | $1.02 | $1.04 | +1.96% | -0.72% | - |
| Jul 23, 2026after close | $0.98 | $1.07 | +9.18% | +1.85% | +5.24% |
| Jan 29, 2026after close | $0.92 | $0.96 | +4.35% | -1.22% | -12.82% |
| Oct 21, 2025after close | $0.85 | $0.88 | +3.53% | -3.22% | -2.62% |
| Jul 24, 2025after close | $0.81 | $0.85 | +4.94% | +1.43% | +2.91% |
| Apr 24, 2025after close | $0.77 | $0.79 | +2.60% | +0.83% | +1.87% |
| Jan 29, 2025after close | $0.75 | $0.76 | +1.33% | +0.67% | +1.38% |
As of October 26, 2026, NDAQ has beaten the analyst EPS estimate in 7 of the 7 reports in our data and fell in the first trading session after 3 of those beats; its latest report, on October 22, 2026, came in 1.96% above the estimate and the stock moved -0.72% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
NDAQ AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 74.2, in overbought territory.RSI above 50 ›
An RSI of 74.2 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank Financial AI analysis of NDAQ
The score, the reasoning behind it, and what could move the price next.
Nasdaq Inc (NDAQ) remains in an uptrend. The price of $104.72 is 10.21% above its 50-day average of $95.02 and 15.74% above its 200-day average of $90.48. Trading near the top of its 52-week range, the price is 0.21% below the high of $104.94 and 36.80% above the low of $76.55. The 50-day average is 5.02% above the 200-day, so the two averages are also arranged in an uptrend.
NDAQ's 14-day RSI sits at 74.2, which places it in overbought territory, while the MACD line is positive. Returns back this up: over the past three months the price rose 11.48%, over the past six months it rose 15.80%, and over the past year it rose 18.41%.
Rating reaffirmed ›
Goldman Sachs kept its Buy rating on October 23, 2026.
Source: Analyst action, Goldman Sachs, October 23, 2026
Earnings beat, but the stock fell ›
The October 22, 2026 report beat the EPS estimate by 1.96%, and the share price fell 0.72% in the first session after it.
Source: Earnings report, October 22, 2026
- Two levels matter most right now: the 52-week high at $104.94 sits above the price, and the 20-day EMA at $96.15 sits below it.
- A 14-day RSI of 74.2 places NDAQ in the overbought zone, and the MACD line is positive. Readings above 70 or below 30 signal stretched momentum.
- The share price fell 0.72% in the first session after the October 22, 2026 report.
NDAQ's uptrend depends on the price holding above its 50-day average of $95.02 and its 200-day average of $90.48. A close below the 50-day would be the first sign of that trend weakening. If the price pulls back, the first level it would reach is the 20-day EMA, at $96.15.
The next level overhead for NDAQ is the 52-week high at $104.94.
Technical indicators
Momentum and trend for NDAQ, from its daily closes.
As of October 26, 2026, with NDAQ at $104.72, its 14-day RSI is 74.2 (overbought territory), its 50-day simple moving average is $95.02 and its 200-day is $90.48.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What NDAQ moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, NDAQ's 1-year correlation of daily returns is +0.50 with S&P 500 (SPY), +0.39 with Nasdaq 100 (QQQ), +0.27 with Bitcoin (BTC) and +0.00 with gold (XAU).
NDAQ price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
14 of 18 analysts rate it a buy or strong buy, 3 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $115.50 is 10.3% above the price.More buy ratings than three months ago ›
14 of 18 rate it a buy now, against 14 of 17 three months ago.
NDAQ Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 23, 2026 | Goldman Sachs | Maintains | Buy |
| Oct 23, 2026 | Morgan Stanley | Maintains | Overweight |
| Oct 23, 2026 | JP Morgan | Maintains | Overweight |
| Oct 23, 2026 | Wells Fargo | Maintains | Equal-Weight |
| Oct 23, 2026 | Barclays | Maintains | Overweight |
| Oct 12, 2026 | TD Cowen | Maintains | Buy |
As of October 26, 2026, 18 Wall Street analysts cover NDAQ: 14 rate it a buy or strong buy, 3 a hold and 1 a sell or strong sell. Their 12-month price targets range from $87.00 to $133.00. The median NDAQ price target is $115.50, 10.3% above the price of $104.72.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
NDAQ trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
NDAQ trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from NDAQ's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much NDAQ tends to move, against the market and on its own.
NDAQ price history and drawdowns
NDAQ's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
4/4Average daily move under 2% ›
The price has moved 1.79% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 30.9%, from November 2021 to May 2022, regained by August 2024.Most 1-year holds ended higher ›
82% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $57,496, against $42,015 in the S&P 500 (SPY).
NDAQ Drawdowns & Recovery
As of October 26, 2026, NDAQ's worst peak-to-trough fall over the last 10 years with dividends reinvested was -30.9% (November 2021 to May 2022); it regained that peak by August 2024, 27 months after the low, and 82% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into NDAQ in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: NDAQ beat the S&P 500 over this period: $57,496 against $42,015.
A $10,000 investment in NDAQ in October 2016 would be worth about $57,496 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to NDAQ, and which have not.
Strongest month, July: an average of +7.57%, up in 10 of 10 years.
Weakest month, September: an average of -2.35%, up in 4 of 10 years.
This month, October: has averaged +0.53%, up in 5 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, NDAQ's strongest calendar month has been July (average +7.57%, up in 10 of 10 years) and its weakest September (average -2.35%, up in 4 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
NDAQ stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in NDAQ, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in NDAQ today could grow to about $14,504 by 2030 in the base case, with a 90th-percentile outcome near $27,464 and a 10th-percentile outcome around $7,660. The simulation models price only; at today's 1.15% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
NDAQ Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $152 for NDAQ by 2030 in the base case, from $105 today (1.5x over 4 years). The 10th-percentile path ends near $80.21. These are outcomes of a Monte Carlo simulation run on NDAQ's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $83.52 | $115 | $158 | |
| 2028 | $80.30 | $126 | $198 | |
| 2029 | $79.62 | $138 | $241 | |
| 2030 | $80.21 | $152 | $288 |
Method: a lognormal simulation of NDAQ's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
NDAQ insider trading
What the people running the company have bought and sold.
NDAQ insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: Insiders bought $16.8M on the open market and sold $91.2M.
As of October 26, 2026, NDAQ insiders reported 39 open-market sales worth $91.2M and 2 open-market purchases worth $16.8M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 20, 2026 | Jeremy Skule
Officer
|
Sell | 1.1K | $106.9K |
| Oct 12, 2026 | Jeremy Skule
Officer
|
Sell | 1.1K | $105.9K |
| Sep 22, 2026 | Jeremy Skule
Officer
|
Sell | 1.1K | $106.9K |
| Sep 10, 2026 | Jeremy Skule
Officer
|
Sell | 1.1K | $106.0K |
| Aug 10, 2026 | P C Nelson Griggs
Officer
|
Sell | 3.2K | $310.2K |
| Aug 10, 2026 | Jeremy Skule
Officer
|
Sell | 2.3K | $213.2K |
| Aug 7, 2026 | Bradley J. Peterson
Chief Technology Officer
|
Sell | 6.0K | $573.3K |
| Aug 3, 2026 | Bryan Everard Smith
Officer
|
Sell | 1.6K | $147.9K |
| Jul 29, 2026 | P C Nelson Griggs
Officer
|
Sell | 11.0K | $1.1M |
| Jul 27, 2026 | P C Nelson Griggs
Officer
|
Sell | 17.8K | $1.7M |
| Jul 24, 2026 | Bradley J. Peterson
Chief Technology Officer
|
Sell | 13.0K | $1.2M |
| Jul 1, 2026 | Bryan Everard Smith
Officer
|
Sell | 3.0K | $240.0K |
| Jun 11, 2026 | Bryan Everard Smith
Officer
|
Sell | 3.0K | $260.7K |
| Jun 10, 2026 | Melissa Arnoldi
Director
|
Grant | 4.3K | - |
| Jun 10, 2026 | Charlene T Begley
Director
|
Grant | 3.0K | - |
| Jun 10, 2026 | Essa Kazim
Director
|
Grant | 4.2K | - |
| Jun 10, 2026 | Thomas Archie Kloet
Director
|
Grant | 4.6K | - |
| Jun 10, 2026 | Kathryn A Koch
Director
|
Grant | 3.2K | - |
| Jun 10, 2026 | Paul Holden Spaht Jr
Director
|
Grant | 3.0K | - |
| Jun 10, 2026 | Michael R Splinter
Director
|
Grant | 5.2K | - |
| Jun 10, 2026 | Johan Torgeby
Director
|
Grant | 3.0K | - |
| Jun 10, 2026 | Toni Townes-Whitley
Director
|
Grant | 3.0K | - |
| Jun 10, 2026 | Jeffery William Yabuki
Director
|
Grant | 4.6K | - |
| Jun 10, 2026 | Alfred W Zollar
Director
|
Grant | 4.5K | - |
| May 18, 2026 | P C Nelson Griggs
Officer
|
Sell | 5.1K | $471.7K |
| Apr 28, 2026 | Bradley J. Peterson
Chief Technology Officer
|
Sell | 7.7K | $700.2K |
| Apr 27, 2026 | Cohen Tal
Officer
|
Sell | 15.5K | $1.4M |
| Apr 24, 2026 | Michelle Lynn Daly
Officer
|
Sell | 1.3K | $117.5K |
| Apr 1, 2026 | Adena T Friedman
Chief Executive Officer
|
Sell | 113.6K | $9.7M |
| Apr 1, 2026 | Michelle Lynn Daly
Officer
|
Grant | 2.0K | - |
| Apr 1, 2026 | Adena T Friedman
Chief Executive Officer
|
Option | 113.6K | $2.5M |
| Apr 1, 2026 | Adena T Friedman
Chief Executive Officer
|
Grant | 39.9K | - |
| Apr 1, 2026 | P C Nelson Griggs
Officer
|
Grant | 11.7K | - |
| Apr 1, 2026 | Bradley J. Peterson
Chief Technology Officer
|
Grant | 8.1K | - |
| Apr 1, 2026 | Jeremy Skule
Officer
|
Grant | 7.6K | - |
| Apr 1, 2026 | Bryan Everard Smith
Officer
|
Grant | 7.0K | - |
| Apr 1, 2026 | Cohen Tal
Officer
|
Grant | 15.3K | - |
| Apr 1, 2026 | Sarah Youngwood
Chief Financial Officer
|
Grant | 15.3K | - |
| Apr 1, 2026 | John Zecca
Officer
|
Grant | 7.3K | - |
| Mar 11, 2026 | Adena T Friedman
Chief Executive Officer
|
Grant | 113.6K | - |
| Mar 6, 2026 | Adena T Friedman
Chief Executive Officer
|
Sell | 92.8K | $8.4M |
| Mar 6, 2026 | Adena T Friedman
Chief Executive Officer
|
Option | 92.8K | $2.1M |
| Mar 2, 2026 | Bryan Everard Smith
Officer
|
Sell | 6.0K | $523.4K |
| Feb 19, 2026 | Michelle Lynn Daly
Officer
|
Sell | 4.3K | $352.9K |
| Feb 17, 2026 | Johan Torgeby
Director
|
Buy | 12.0K | $958.3K |
| Feb 13, 2026 | Ab Investor
Beneficial Owner of more than 10% of a Class of Security
|
Buy | 200.0K | $15.8M |
| Feb 12, 2026 | Adena T Friedman
Chief Executive Officer
|
Grant | 270.2K | - |
| Feb 11, 2026 | Michelle Lynn Daly
Officer
|
Grant | 8.7K | - |
| Feb 11, 2026 | P C Nelson Griggs
Officer
|
Grant | 56.8K | - |
| Feb 11, 2026 | Bradley J. Peterson
Chief Technology Officer
|
Grant | 53.6K | - |
| Feb 11, 2026 | Jeremy Skule
Officer
|
Grant | 34.4K | - |
| Feb 11, 2026 | Bryan Everard Smith
Officer
|
Grant | 29.1K | - |
| Feb 11, 2026 | Cohen Tal
Officer
|
Grant | 56.8K | - |
| Feb 11, 2026 | John Zecca
Officer
|
Grant | 32.6K | - |
| Feb 2, 2026 | Adena T Friedman
Chief Executive Officer
|
Sell | 300.0K | $29.1M |
| Feb 2, 2026 | Adena T Friedman
Chief Executive Officer
|
Option | 300.0K | $6.7M |
| Jan 30, 2026 | Michael R Splinter
Director
|
Grant | 4.7K | - |
| Jan 6, 2026 | John Zecca
Officer
|
Sell | 4.5K | $450.0K |
| Jan 2, 2026 | Adena T Friedman
Chief Executive Officer
|
Sell | 300.0K | $28.9M |
| Jan 2, 2026 | Adena T Friedman
Chief Executive Officer
|
Option | 300.0K | $6.7M |
| Dec 1, 2025 | Bryan Everard Smith
Officer
|
Sell | 4.6K | $419.6K |
| Dec 1, 2025 | Jeremy Skule
Officer
|
Sell | 2.1K | $190.7K |
| Nov 3, 2025 | Jeremy Skule
Officer
|
Sell | 2.1K | $179.8K |
| Oct 1, 2025 | Jeremy Skule
Officer
|
Sell | 2.1K | $185.7K |
| Sep 2, 2025 | Jeremy Skule
Officer
|
Sell | 2.1K | $196.2K |
| Aug 4, 2025 | Charlene T Begley
Director
|
Sell | 3.0K | $289.8K |
| Aug 1, 2025 | Jeremy Skule
Officer
|
Sell | 2.1K | $201.0K |
| Jul 25, 2025 | Michelle Lynn Daly
Officer
|
Sell | 8.7K | $812.2K |
| Jul 2, 2025 | Bradley J. Peterson
Chief Technology Officer
|
Sell | 11.5K | $1.0M |
| Jul 1, 2025 | Jeremy Skule
Officer
|
Sell | 2.1K | $187.7K |
| Jun 11, 2025 | Melissa Arnoldi
Director
|
Grant | 4.3K | - |
| Jun 11, 2025 | Charlene T Begley
Director
|
Grant | 3.0K | - |
| Jun 11, 2025 | Essa Kazim
Director
|
Grant | 4.1K | - |
| Jun 11, 2025 | Thomas Archie Kloet
Director
|
Grant | 4.5K | - |
| Jun 11, 2025 | Kathryn A Koch
Director
|
Grant | 3.2K | - |
| Jun 11, 2025 | Paul Holden Spaht Jr
Director
|
Grant | 3.0K | - |
| Jun 11, 2025 | Michael R Splinter
Director
|
Grant | 5.2K | - |
| Jun 11, 2025 | Johan Torgeby
Director
|
Grant | 3.0K | - |
| Jun 11, 2025 | Toni Townes-Whitley
Director
|
Grant | 3.0K | - |
| Jun 11, 2025 | Jeffery William Yabuki
Director
|
Grant | 4.6K | - |
| Jun 11, 2025 | Alfred W Zollar
Director
|
Grant | 4.5K | - |
| Jun 6, 2025 | P C Nelson Griggs
Officer
|
Sell | 4.0K | $340.9K |
| Jun 6, 2025 | Jeremy Skule
Officer
|
Sell | 2.1K | $178.8K |
| Jun 4, 2025 | Paul Holden Spaht Jr
Director
|
Grant | 447.2K | - |
| Jun 2, 2025 | Jeremy Skule
Officer
|
Sell | 1.1K | $87.7K |
| May 27, 2025 | P C Nelson Griggs
Officer
|
Sell | 8.0K | $664.2K |
| May 12, 2025 | Jeremy Skule
Officer
|
Sell | 1.1K | $85.8K |
Source: TwelveData, from SEC Form 4 filings
NDAQ stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.